ILIKOS Consulting Group, a Cyprus-based company that offers services to Contract Research Organisations (CROs) and life science companies, announced on Tuesday that it has partnered with Jordan Center for Pharmaceutical Research (JCPR), a pharmaceutical research facility in Jordan.

The partnership is aimed at highlighting the advantages in designing and executing BE/BA studies in Jordan and advancing innovative clinical research across the country.

Elias Sayias, ILIKOS founder and CEO, said: "With increasing global pressures on the generics industry, from regulatory shifts to rising development costs, it's critical to explore innovative and reliable solutions. Jordan's strategic position, combined with JCPR's extensive expertise, offer a compelling value proposition for sponsors navigating the challenges of modern drug development. Our goal is to support bridging cultural, regulatory and operational gaps to deliver cost-effective, high-quality outcomes."